Accelerating your development

Under our Pharmorphix® offering, we have a proven track record of delivering excellence for customers in early drug development. By applying our world-leading understanding of solid form science, we can improve the properties and success rates of drug candidates for the pharmaceutical industry.

We are a trusted and experienced partner, having completed over 2,000 customer projects on a wide range of structurally diverse and complex APIs. Our scientists have a unique understanding of how best to support customers to progress their compounds through the drug development process.

Our state-of-the-art facility based in Cambridge, U.K., offers one of the most comprehensive arrays of integrated solid form, pre-formulation, particle engineering and chemical development capabilities available to the pharmaceutical and biotechnology industries. We have the flexibility and breadth of expertise to adapt to your project’s evolving needs.

A collaborative journey

Long-term partnership

Our success in solid form sciences is built on strong partnership and collaboration.

We work closely with our customers to fully understand their solid form and particle engineering needs; providing the right recommendation at an early stage: our unbiased approach to technology selection means we have the knowledge and expertise to be able to select the right technology using as small amounts of material as possible.

We’re delighted to have achieved an average Net Promoter Score (NPS) of 85% over the past two years up to Sept 2023.

Collaborate with Veranova

Leading technology

Our comprehensive and industry-leading range of technologies, together with our extensive experience in handling highly potent APIs and IP creation through particle science, give you the best results with confidence.

We commit to building strong relationships through experienced advisers that understand the industry; utilizing our unparalleled ability to work on small quantities from an early stage throughout your process.

Featured insights from our experts

Read more

Antibody-drug conjugate development: challenges and opportunities

By selectively delivering highly potent APIs to cancer cells, they offer a range of improved patient outcomes, including reduced side effects and higher drug tolerability.

Understanding the formation of cocrystals

Cocrystals play an increasingly vital role in drug development, with specialist techniques required to identify and develop them.

Continuous manufacturing (flow chemistry) - the future of pharmaceutical manufacturing

Continuous manufacturing offers several advantages over traditional batch manufacturing, including increased efficiency, reduced waste, and improved product quality.

Veranova is your next great decision

Discover new ways to advance your science with Veranova.

Contact us